Literature DB >> 25788375

Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Louise Madeleine Risør1, Flemming Bendtsen, Søren Møller.   

Abstract

Acute kidney injury (AKI) is one of the most severe complications of cirrhosis and is associated with significant morbidity and mortality. Liver fibrosis and liver insufficiency, portal hypertension, systemic vasodilation, and a subsequent hyperdynamic circulation undermine the renal and cardiac function, making cirrhotic patients more susceptible to hemodynamic incidents. In addition, the immune system is impaired in cirrhosis, leading to an exaggerated production of vasoactive mediators, and the adrenal cortisol response is insufficient, which causes further impairment of the vascular tonus, cardiac output, and renal perfusion. Consequently, the cardiovascular and renal dysfunction is aggravated, resulting in a hepatorenal syndrome (HRS). HRS is seen exclusively in patients with liver disease and has been considered an entirely functional prerenal dysfunction, rather than a structural dysfunction, but is not responsive to volume expansion. Recent research indicates that development of hepatic nephropathy represents a continuous spectrum of functional and structural dysfunction and may be precipitated by the inherent immunologic, adrenal, and hemodynamic incompetence in cirrhosis. New research explores several new markers of renal dysfunction that may replace serum creatinine in the future and give new insight on the hepatic nephropathy. Our understanding of the pathophysiological mechanisms causing the immunologic, adrenal, and hemodynamic incompetence, and the impact on renal dysfunction, has improved in recent years, and in this review we aim to highlight recent achievements in this field.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25788375     DOI: 10.1007/s12072-014-9581-1

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  70 in total

1.  Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.

Authors:  Pablo Bellot; Juan Carlos García-Pagán; Rubén Francés; Juan G Abraldes; Miguel Navasa; Miguel Pérez-Mateo; José Such; Jaime Bosch
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

Review 2.  The sympathetic nervous system in liver disease.

Authors:  J H Henriksen; S Møller; H Ring-Larsen; N J Christensen
Journal:  J Hepatol       Date:  1998-08       Impact factor: 25.083

3.  Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.

Authors:  Mohammed A Sharawey; Eglal M Shawky; Lamia H Ali; Ahmed Ali Mohammed; Hatem A Hassan; Yasser M Fouad
Journal:  Hepatol Int       Date:  2011-03-12       Impact factor: 6.047

4.  Serum cystatin C in advanced liver cirrhosis and different stages of the hepatorenal syndrome.

Authors:  Maha Barakat; Mohamed Khalil
Journal:  Arab J Gastroenterol       Date:  2011-08-30       Impact factor: 2.076

Review 5.  Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

Authors:  F Wong; M Bernardi; R Balk; B Christman; R Moreau; G Garcia-Tsao; D Patch; G Soriano; J Hoefs; M Navasa
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

6.  Clinical applications of biomarkers for acute kidney injury.

Authors:  Justin M Belcher; Charles L Edelstein; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2011-03-15       Impact factor: 8.860

7.  Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study.

Authors:  Gokhan Gungor; Huseyin Ataseven; Ali Demir; Yalcin Solak; Abduzhappar Gaipov; Murat Biyik; Bahadir Ozturk; Ilker Polat; Aysel Kiyici; Ozlem O Cakir; Hakki Polat
Journal:  Liver Int       Date:  2013-06-26       Impact factor: 5.828

8.  Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels.

Authors:  Yeon Seok Seo; Eun Suk Jung; Hyonggin An; Jeong Han Kim; Young Kul Jung; Ji Hoon Kim; Hyung Joon Yim; Jong Eun Yeon; Kwan Soo Byun; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  Liver Int       Date:  2009-09-02       Impact factor: 5.828

9.  The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.

Authors:  Ken Ishikawa; Li Wan; Paolo Calzavacca; Rinaldo Bellomo; Michael Bailey; Clive N May
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  1 in total

1.  The efficacy of biomarkers in the diagnosis of acute kidney injury secondary to liver cirrhosis.

Authors:  Yuwei Yang; Bin Ge; Yan Liu; Jiafu Feng
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.